Items tagged with Treatment

Landmark clinical trial redefines multidrug-resistant TB treatment options (post with simple image)

endTB clinical trial offers multiple new shortened drug regimens to treat adults and children with multidrug–resistant TB.

High cure rate with drug-resistant TB regimen (post with simple image)

Results of LIFT-TB operational research on BPaL regimen for treating drug-resistant TB in Central and Southeast Asia.

TB Alliance launches five-country Phase 2 clinical trial evaluating next-generation TB drug (post with simple image)

A combination of a new experimental compound, TBAJ-876, with pretomanid and linezolid, has the potential to become a 'universal TB regimen', shortening and improving treatment for both drug-sensitive and drug-resistant TB.

Survey: Core outcome set for Phase 3 studies of pulmonary TB treatment (post with simple image)

An international survey seeks to determine the most important outcomes to measure in Phase 3 trials of pulmonary TB treatment.

(post with simple image)

Technical brief: Access to TB testing and treatments: GeneXpert and delamanid (post with simple image)

Médecins Sans Frontières issues a report offering case studies of two critical TB tools, GeneXpert and delamanid, and outlining actions that the corporations making them need to take to unlock access to these tools.

Addressing the needs of people with extensively drug-resistant TB through pre-approval access to drugs and research (post with simple image)

A viewpoint, published in Public Health Action, advocates for transparent, accessible pre-approval access as a core element of person-centered care for drug-resistant TB.

Call to Action: Shorter and more effective treatment for all people suffering from drug-resistant TB (post with simple image)

Sign up for a Call to Action for accelerating the implementation of shorter and more effective treatment for all people with drug-resistant TB.

Survey: Provider attitudes to, and interest in, long-acting formulations of TB treatment (post with simple image)

Healthcare providers and policymakers in LMICs are invited to take part in an online survey assessing their perspectives on long-acting TB preventive treatment.

The rejection of the bedaquiline patent opposition in Indonesia raises the risk of difficulty in accessing optimal TB therapy (post with simple image)

The patent opposition was submitted by the Indonesia AIDS Coalition and Indonesia for Global Justice in November 2022 and was rejected by a decision from the Judiciary Panel on 9 November 2023.